Longeveron Inc - Ordinary Shares - Class A

NASDAQ:LGVN 4:00:00 PM EDT

2.01

-0.08 (-3.83%)

7:57:12 PM EDT: $2.05 +0.04 (+1.95%)

Market Cap (Intraday)	6.53M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.05 Million
Adjusted EPS	-$2.15

See more estimates

10-Day MA	$2.44
50-Day MA	$4.15
200-Day MA	$17.06

See more pivots

Longeveron Inc - Ordinary Shares - Class A Stock, NASDAQ:LGVN

Life Science & Technology Park, 1951 Northwest 7th Avenue, Miami, Florida 33136

United States of America

Phone: +1.305.909.0840

Number of Employees: 25

http://www.longeveron.com

Description

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.